Robert J Gould
CIK 1577034 · Interim President & CEO · last filed 2026-02-04
Robert J Gould is an Interim President & CEO who has filed 42 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider sold $163.1K of FULC on Feb 4, 2026. Across all open-market trades the lifetime net is −$16.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.62M
3
42
-$16.34M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FULC | Director | 469,864 | $3.45 | $1.62M | -$5.10M | 28 | 2026-02-04 |
| Turnstone Biologics Corp. (TSBX) Delisted | Director | — | $0.35 | — | $0 | 1 | 2024-07-02 |
| Epizyme, Inc. (EPZM) Delisted | President & CEO | 0 | $1.47 | $0 | -$11.24M | 13 | 2015-12-31 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-04 | FULC | Sell (S) | −15,000 | -$163.1K | EDGAR |
| 2026-02-04 | FULC | Sell (S) | −15,000 | -$160.9K | EDGAR |
| 2026-01-06 | FULC | Sell (S) | −15,000 | -$178.1K | EDGAR |
| 2025-11-21 | FULC | Sell (S) | −15,000 | -$165.5K | EDGAR |
| 2025-06-30 | FULC | Grant (A) | — | $0 | EDGAR |
| 2024-07-02 | Turnstone Biologics Corp. (TSBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | FULC | Grant (A) | — | $0 | EDGAR |
| 2023-06-29 | FULC | Grant (A) | — | $0 | EDGAR |
| 2023-01-13 | FULC | Sell (S) | −6,766 | -$101.5K | EDGAR |
| 2022-06-29 | FULC | Grant (A) | — | $0 | EDGAR |